Vanguard Group Inc Athersys, Inc Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $4.5 $1.69 Million - $44.8 Million	-9,946,969 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.18 - $0.86 $187,195 - $894,379	-1,039,976 Reduced 9.47%	9,946,969 $2.59 Million
Q1 2022 May 13, 2022	BUY	$0.6 - $1.06 $546,300 - $965,131	910,501 Added 9.04%	10,986,945 $6.65 Million
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $106,416 - $175,274	-125,196 Reduced 1.23%	10,076,444 $9.1 Million
Q3 2021 Nov 12, 2021	BUY	$1.33 - $1.77 $474,954 - $632,082	357,109 Added 3.63%	10,201,640 $13.6 Million
Q2 2021 Aug 13, 2021	BUY	$1.41 - $1.94 $13.9 Million - $19.1 Million	9,844,531 New	9,844,531 $14.2 Million

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.